Clinical Trial Update: Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders [NA]

View source ↗

Summary

This clinical trial update describes an ex vivo evaluation of a JAK-inhibitor and a gene-therapy approach for JAK-STAT related disorders, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Diseases

Snippet

Sponsor: prof. dr. Rik Schrijvers | Conditions: Primary Immunodeficiency Diseases (PID) | NA | Status: RECRUITING